ASSEMBLY BIOSCIENCES, INC. (ASMB) › Cash & EquivalentsASSEMBLY BIOSCIENCES, INC. (ASMB) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2005: $02008: $15.9K2009: $81.3K2010: $14.57M2011: $36.98M2012: $20.49M2013: $27.06M2014: $29.09M2015: $27.11M2016: $28.57M2017: $82.03M2018: $41.47M2019: $46.73M2020: $59.44M2021: $45.63M2022: $52.42M2023: $19.84M2024: $38.34M2025: $58.45M$58.45M2005Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$58.45M+52.4%2024$38.34M+93.3%2023$19.84M-62.1%2022$52.42M+14.9%2021$45.63M-23.2%2020$59.44M+27.2%2019$46.73M+12.7%2018$41.47M-49.4%2017$82.03M+187.1%2016$28.57M+5.4%2015$27.11M-6.8%2014$29.09M+7.5%2013$27.06M+32.1%2012$20.49M-44.6%2011$36.98M+153.8%2010$14.57M+17825.2%2009$81.3K+412.8%2008$15.9K—2005$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share